Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Prolymphocytic, B-Cell × ibrutinib × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 42 Lymphoma, Mantle-Cell 17 Lymphoma, Follicular 12 Waldenstrom Macroglobulinemia 11 Lymphoma, Large B-Cell, Diffuse 9 Lymphoma, B-Cell 9 Lymphoma 9 Lymphoma, Non-Hodgkin 8 Leukemia 8 Recurrence 7 Multiple Myeloma 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Lymphoid 4 Leukemia, B-Cell 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms, Plasma Cell 2 Lung Neoplasms 2 Leukemia, Prolymphocytic 2 Leukemia, Myeloid, Acute 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Chromosome 17 deletion 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Burkitt Lymphoma 2 Bronchiolitis Obliterans Syndrome 2 Smoldering Multiple Myeloma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1

Interventions

fludarabine phosphate 2 Whole-Body Irradiation 2 Mycophenolic Acid 2 obinutuzumab 1 letermovir 1 carmustine, poliferprosan 20 drug combination 1 Tacrolimus 1 Stem Cell Transplantation 1 Peripheral Blood Stem Cell Transplantation 1 Melphalan 1 Hematopoietic Stem Cell Transplantation 1 Etoposide 1 Cytarabine 1 Cyclosporins 1 Cyclosporine 1 Cyclophosphamide 1 Carmustine 1 6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡